- Protein chips are essential tools in proteomics, enabling high-throughput analysis of protein interactions, functions, and expressions for applications in diagnostics, drug discovery, and biomarker identification
- The demand for protein chips is driven by advancements in proteomic research, increasing focus on personalized medicine, and the growing prevalence of chronic and infectious diseases
- North America is expected to dominate the protein chip market holding a market share of estimated 48.67%, driven by strong research infrastructure, high adoption of cutting-edge proteomic technologies, and a significant number of pharmaceutical and biotechnology companies
- Asia-Pacific is expected to be the fastest growing region in the protein chip market during the forecast period due to expanding healthcare infrastructure and increasing government support for biomedical research
- The antibody characterization segment is expected to dominate the market with a market share of 56.57% due to its critical role in therapeutic antibody development, disease diagnosis, and biomarker discovery. The growing adoption of monoclonal antibodies in targeted therapies and the need for accurate profiling of antibody specificity and affinity further drive demand
